The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
about
Southern Africa: the Highest Priority Region for HIV Prevention and Care Interventions.Rapid, label-free CD4 testing using a smartphone compatible device.Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic AnalysisA meta-analysis of the performance of the Pima™ CD4 for point of care testing.Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.Implementation of Point-of-Care Diagnostics Leads to Variable Uptake of Syphilis, Anemia and CD4+ T-Cell Count Testing in Rural Maternal and Child Health Clinics.Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South AfricaEvaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal.POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis.Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.Impact and Cost-Effectiveness of Point-Of-Care CD4 Testing on the HIV Epidemic in South Africa.Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges"Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.Current and Future Challenges in Point-of-Care Technologies: A Paradigm-Shift in Affordable Global Healthcare With Personalized and Preventive Medicine.Sustainable HIV treatment in Africa through viral-load-informed differentiated care.The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.Thirty-five years of CD4 T-cell counting in HIV infection: From flow cytometry in the lab to point-of-care testing in the field.An Essential Pathology Package for Low- and Middle-Income Countries.Linkage into care among newly diagnosed HIV-positive individuals tested through outreach and facility-based HIV testing models in Mbeya, Tanzania: a prospective mixed-method cohort study.The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.Treatment outcomes in a rural HIV clinic in South Africa: Implications for health care.Implementation of a point mutation assay for HIV drug resistance testing in KenyaCost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health
P2860
Q30373645-CC3201BA-9226-4843-B817-F4F004682CF4Q33455561-587312E6-30B0-48CD-828A-EC49E456674BQ33737122-A13B085F-857E-47F5-8417-BE80F7EC9C6FQ35712626-284280CE-A68C-44DA-93AB-2DFCA91A1868Q35746510-D3298343-460E-46CC-B0AD-ECF9696FC287Q35755780-1BBB12E3-EA12-4A86-9489-E239689472E2Q35935264-2FC9F687-B09F-4991-8C97-5B770B952BA5Q36014143-6907A39C-3C39-4A86-B464-381056492051Q36016661-BE1FDD7F-B11A-4699-BCC8-4088FFC5FC03Q36029182-F95060C3-1D0F-41E8-B4B6-F71F787C6199Q36070274-B09080AB-9BB2-46CF-957A-BAEB30A554A4Q36071013-E456BF76-79A7-44AC-8AEF-40BDC7B7E5D0Q36171165-6A4A59D3-0108-4345-84DB-548D2A9F1025Q36205807-9A5FA73E-E0DD-45F6-88B8-3A1D44D2775EQ36224801-BB1B3A75-9415-4A15-953C-5FBF6ED66492Q36715819-5863CED4-A050-4B0E-AA23-3FFED1BA2B9FQ36792064-173B98C1-6892-48BE-8DE8-26BE8CBE58F8Q36844458-0C095C6A-0165-4AA6-A92C-793B71886962Q37064741-BB44FDA5-1C91-415F-A0BE-FCCB91A1FE55Q37235371-D19D3E4B-F9B8-4AB1-8774-CCB082133238Q38605530-DEFF4C56-DF5B-4DBD-9D64-88E310A02843Q38842566-DF322308-A752-4C8D-8021-4DDE81571753Q39118061-549962B7-4EC1-4706-B1EC-35CF93740799Q39428548-831DCF39-EAA6-491D-8FC9-AA3986F21018Q40041518-124636AE-2FED-4732-AEC2-CD9716A43791Q46388033-70CAC4DA-B26C-4E05-8254-2FB0CE2CFA60Q52604813-25ACD195-549D-4915-BB60-3398142A6F54Q53759790-EC6278E3-5C17-4B47-8425-44CEFF4E1715Q53762202-232F7478-C072-4CCA-8E5C-9A10114D06AAQ57131360-CBA30200-9258-43E1-BB2A-84035610E0F9Q58734720-D5B0F2BC-5B1A-4238-A3DE-40A07B69F0FB
P2860
The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The clinical and economic impa ...... a cost-effectiveness analysis.
@ast
The clinical and economic impa ...... a cost-effectiveness analysis.
@en
The clinical and economic impa ...... a cost-effectiveness analysis.
@nl
type
label
The clinical and economic impa ...... a cost-effectiveness analysis.
@ast
The clinical and economic impa ...... a cost-effectiveness analysis.
@en
The clinical and economic impa ...... a cost-effectiveness analysis.
@nl
prefLabel
The clinical and economic impa ...... a cost-effectiveness analysis.
@ast
The clinical and economic impa ...... a cost-effectiveness analysis.
@en
The clinical and economic impa ...... a cost-effectiveness analysis.
@nl
P2093
P2860
P50
P1433
P1476
The clinical and economic impa ...... a cost-effectiveness analysis.
@en
P2093
A David Paltiel
Amanda E Su
Emily P Hyle
Jonathan Lehe
Jorge Quevedo
Pamela P Pei
Stephen Resch
Trevor Peter
P2860
P304
P356
10.1371/JOURNAL.PMED.1001725
P407
P577
2014-09-16T00:00:00Z